Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Inhibition of smooth muscle myosin as a novel therapeutic target for hypertension.

Zhao X, Ho D, Abarzúa P, Dhar SK, Wang X, Jia Z, Pannirselvam M, Morgans DJ, Malik FI, Vatner SF.

J Pharmacol Exp Ther. 2011 Oct;339(1):307-12. doi: 10.1124/jpet.111.182402. Epub 2011 Jul 22.

2.

Caloric restriction reduces growth of mammary tumors and metastases.

De Lorenzo MS, Baljinnyam E, Vatner DE, Abarzúa P, Vatner SF, Rabson AB.

Carcinogenesis. 2011 Sep;32(9):1381-7. doi: 10.1093/carcin/bgr107. Epub 2011 Jun 10.

3.

Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.

Shen YT, Malik FI, Zhao X, Depre C, Dhar SK, Abarzúa P, Morgans DJ, Vatner SF.

Circ Heart Fail. 2010 Jul;3(4):522-7. doi: 10.1161/CIRCHEARTFAILURE.109.930321. Epub 2010 May 24.

4.

High accuracy genotyping directly from genomic DNA using a rolling circle amplification based assay.

Alsmadi OA, Bornarth CJ, Song W, Wisniewski M, Du J, Brockman JP, Faruqi AF, Hosono S, Sun Z, Du Y, Wu X, Egholm M, Abarzúa P, Lasken RS, Driscoll MD.

BMC Genomics. 2003 May 30;4(1):21. Epub 2003 May 30.

5.

Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells.

Kim AL, Raffo AJ, Brandt-Rauf PW, Pincus MR, Monaco R, Abarzua P, Fine RL.

J Biol Chem. 1999 Dec 3;274(49):34924-31.

6.

Characterization of the chimeric retinoic acid receptor RARalpha/VDR.

Pemrick SM, Abarzúa P, Kratzeisen C, Marks MS, Medin JA, Ozato K, Grippo JF.

Leukemia. 1998 Apr;12(4):554-62.

PMID:
9557614
7.

Restoration of the transcription activation function to mutant p53 in human cancer cells.

Abarzúa P, LoSardo JE, Gubler ML, Spathis R, Lu YA, Felix A, Neri A.

Oncogene. 1996 Dec 5;13(11):2477-82.

PMID:
8957091
9.

Nonradioactive assay for sequence-specific DNA binding proteins.

Gubler ML, Abarzúa P.

Biotechniques. 1995 Jun;18(6):1008, 1011-4.

PMID:
7546700
10.

Distinct binding determinants for 9-cis retinoic acid are located within AF-2 of retinoic acid receptor alpha.

Tate BF, Allenby G, Janocha R, Kazmer S, Speck J, Sturzenbecker LJ, Abarzúa P, Levin AA, Grippo JF.

Mol Cell Biol. 1994 Apr;14(4):2323-30.

11.

Characterization of a retinoic acid responsive element isolated by whole genome PCR.

Costa-Giomi MP, Gaub MP, Chambon P, Abarzúa P.

Nucleic Acids Res. 1992 Jun 25;20(12):3223-32.

12.
13.

Differentiation of embryonal carcinoma cells in response to retinoids.

Abarzúa P, Sherman MI.

Methods Enzymol. 1990;189:337-48. No abstract available.

PMID:
2292944
14.

Regulation and patterns of endogenous and exogenous gene expression during differentiation of embryonal carcinoma cells.

Astigiano S, Sherman MI, Abarzúa P.

Environ Health Perspect. 1989 Mar;80:25-38. Review.

16.
17.

Supplemental Content

Loading ...
Support Center